Anatomy of female reproductive system

Reading Document
Medical Text Search

anatomy of female reproductive system organs structure

Medical Image Search

female reproductive system anatomy diagram

GradeResponse
GradeResponse

Anatomy of the Female Reproductive System

The female reproductive system consists of both internal and external organs, primarily located in the pelvic cavity. These structures develop embryologically from the Müllerian (paramesonephric) ducts, which form the uterus, fallopian tubes, cervix, and upper third of the vagina, while the urogenital sinus gives rise to the lower two-thirds of the vagina (Bailey & Love's Surgery, 28th Ed., p. 1596).

Female Reproductive System Anatomy

Internal Organs

1. Ovaries

  • Paired gonads, almond-shaped, ~3 × 2 × 1 cm
  • Located in the ovarian fossa on the lateral pelvic wall
  • Attached to the uterus by the ovarian ligament and to the pelvic wall by the suspensory (infundibulopelvic) ligament
  • Functions: Oogenesis (egg production) and secretion of estrogen and progesterone
  • Cortex contains follicles at varying stages of development (primordial → mature Graafian follicle)

2. Fallopian Tubes (Uterine Tubes)

  • Two muscular tubes, ~10 cm long, extending from the uterine cornua to the ovaries
  • Parts (medial → lateral):
    SegmentFeatures
    Intramural (interstitial)Passes through uterine wall; narrowest part
    IsthmusThick-walled, narrow lumen
    AmpullaWidest; usual site of fertilization
    InfundibulumFunnel-shaped; bears fimbriae that sweep the ovum
  • Lined by ciliated columnar epithelium that facilitates ovum transport

3. Uterus

  • Hollow, pear-shaped muscular organ, ~7.5 × 5 × 2.5 cm (nulliparous)
  • Parts:
    • Fundus — dome above the fallopian tube openings
    • Body (corpus) — main part; contains the triangular uterine cavity
    • Isthmus — narrow junction between body and cervix
    • Cervix — lower cylindrical part; projects into the vagina
  • Layers of the uterine wall:
    LayerDescription
    PerimetriumOuter serosal (peritoneal) covering
    MyometriumThick smooth muscle; contracts during labor
    EndometriumInner glandular lining; undergoes cyclic changes
  • Supports: Held in place by the broad, round, cardinal (Mackenrodt's), and uterosacral ligaments; normal position is anteverted and anteflexed
  • Blood supply: Uterine artery (branch of internal iliac)

4. Cervix

  • Lower cylindrical segment, ~2.5–3 cm long
  • Ectocervix: Covered by stratified squamous epithelium (visible on speculum exam)
  • Endocervix: Lined by mucus-secreting columnar epithelium
  • Transformation zone (squamocolumnar junction): Clinically important site where most cervical cancers arise
  • Internal os opens into the uterine cavity; external os opens into the vagina

5. Vagina

  • Fibromuscular canal, ~8–10 cm long, connecting cervix to the external genitalia
  • Upper third from Müllerian ducts; lower two-thirds from urogenital sinus
  • Lined by stratified squamous epithelium (non-keratinized)
  • Forms fornices (anterior, posterior, and lateral) around the cervix — the posterior fornix is deepest and lies adjacent to the rectouterine pouch (Pouch of Douglas)
  • Functions: Birth canal, menstrual outflow, copulation

External Genitalia (Vulva)

StructureDescription
Mons pubisFatty eminence over the pubic symphysis
Labia majoraTwo large fatty skin folds; homologous to the scrotum
Labia minoraInner thin folds; no subcutaneous fat; enclose the vestibule
ClitorisErectile organ at the anterior junction of labia minora; homologous to the penis
VestibuleSpace between labia minora; contains urethral and vaginal openings
Bartholin's glands(Vestibular glands) Secrete lubricating mucus during arousal
Skene's glands(Paraurethral glands) Adjacent to the urethral orifice
HymenThin membrane partially covering the vaginal opening

Blood Supply Summary

OrganArtery
Uterus & fallopian tubesUterine artery (internal iliac)
OvariesOvarian artery (directly from aorta at L2)
Vagina (upper)Vaginal branches of uterine artery
Vagina (lower)Internal pudendal artery
VulvaInternal & external pudendal arteries

Lymphatic Drainage

OrganPrimary Drainage
OvariesPara-aortic (lumbar) nodes
Uterine bodyInternal/external iliac & para-aortic nodes
CervixInternal iliac, obturator, parametrial nodes
Vagina (upper)Iliac nodes
Vagina (lower) / VulvaSuperficial inguinal nodes

Nerve Supply

  • Sympathetic: T10–L2 (uterus, tubes, ovaries)
  • Parasympathetic: S2–S4 (pelvic splanchnic nerves)
  • Somatic: Pudendal nerve (S2–S4) — external genitalia

Key Anatomical Relations

  • Anteriorly: Bladder and urethra
  • Posteriorly: Rectum; Pouch of Douglas (rectouterine pouch) lies between uterus and rectum — clinically important for ectopic fluid/blood
  • Laterally: Ureters run ~1 cm lateral to the cervix ("water under the bridge" — ureters pass beneath the uterine artery), making them vulnerable during hysterectomy

Chronic hypertension in pregnancy

Medical Text Search

chronic hypertension in pregnancy definition classification diagnosis

Medical Text Search

chronic hypertension pregnancy management treatment antihypertensive drugs

Medical Image Search

chronic hypertension pregnancy complications management

GradeResponse
GradeResponse
GradeResponse

Chronic Hypertension in Pregnancy


Definition

Chronic hypertension in pregnancy is defined as:
  • A pre-existing diagnosis of hypertension, OR
  • SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg on 2 occasions at least 4 hours apart before 20 weeks' gestation
(ACC/AHA Guidelines on High Blood Pressure in Adults, p. 64)
It is distinguished from gestational hypertension and preeclampsia, which arise at or after 20 weeks.

Classification of Hypertensive Disorders of Pregnancy

DisorderOnsetKey Features
Chronic hypertension< 20 weeks or pre-existingNo proteinuria required; persists postpartum
Gestational hypertension≥ 20 weeksNo proteinuria; resolves postpartum
Preeclampsia≥ 20 weeksHTN + proteinuria or end-organ damage
Superimposed preeclampsia≥ 20 weeks in chronic HTN patientWorsening HTN + new proteinuria/end-organ damage
EclampsiaAny timePreeclampsia + seizures

Risks & Complications

Women with chronic hypertension face elevated maternal and fetal risks (Harrison's, 21st Ed., p. 13634):
Maternal:
  • Superimposed preeclampsia (most important complication; risk 15–25%)
  • Placental abruption
  • Stroke / hypertensive crisis
  • Renal deterioration
  • Cardiac failure (in severe/long-standing HTN)
Fetal/Neonatal:
  • Intrauterine growth restriction (IUGR)
  • Preterm birth
  • Placental insufficiency
  • Perinatal mortality (increased)

Pre-pregnancy & Early Pregnancy Evaluation

A thorough assessment should include (Harrison's, 21st Ed., p. 13634):
  1. Identify secondary/remediable causes of hypertension
  2. End-organ assessment — renal function, proteinuria (baseline), cardiac evaluation, fundoscopy
  3. Transition off teratogenic antihypertensives (especially ACE inhibitors and ARBs) before conception or as soon as pregnancy is confirmed
  4. Baseline proteinuria — helps differentiate pre-existing renal disease from later-developing preeclampsia

Blood Pressure Targets in Pregnancy

ParameterTarget
Systolic BP130–150 mmHg
Diastolic BP80–100 mmHg
Emergency thresholdSBP ≥ 160 or DBP ≥ 110 → immediate hospitalization
Targets balance maternal safety (preventing stroke, end-organ damage) with fetal perfusion (avoiding uteroplacental insufficiency from over-aggressive lowering). (Harrison's, p. 13634; Management of Elevated BP Guidelines, p. 60)

Antihypertensive Drug Management

First-Line Agents (Safe in Pregnancy)

DrugClassNotes
Labetalolα/β-blockerMost commonly used; IV form for acute management
Nifedipine (extended-release)Dihydropyridine CCBOral; preferred for outpatient chronic management
MethyldopaCentral α2-agonistLong safety record; less preferred due to side effects
(Harrison's, p. 13634; Management of Elevated BP Guidelines, p. 60)

Contraindicated in Pregnancy

Drug ClassReason
ACE inhibitors (e.g., enalapril, lisinopril)Fetotoxic — renal dysgenesis, oligohydramnios, skull hypoplasia
Angiotensin Receptor Blockers (ARBs)Same mechanism as ACEi; equally teratogenic
Direct renin inhibitors (e.g., aliskiren)Insufficient safety data; avoid
Mineralocorticoid receptor antagonists (e.g., spironolactone)Anti-androgenic effects on fetus

Management Guidelines Summary

Hypertension in Pregnancy Management Recommendations
(Management of Elevated Blood Pressure and Hypertension Guidelines, p. 60)

Monitoring During Pregnancy

  • Frequent antenatal visits — every 2–4 weeks (more frequent if poorly controlled)
  • BP monitoring: Home BP monitoring (HBPM) and/or ambulatory BP monitoring (ABPM) to exclude white-coat and masked hypertension (more common in pregnancy)
  • Urine protein at each visit — early detection of superimposed preeclampsia
  • Fetal surveillance: Serial growth ultrasounds (every 4 weeks from 28 weeks), umbilical artery Doppler, non-stress tests
  • Labs: Renal function, LFTs, CBC, uric acid

Delivery Planning

ScenarioTiming
Well-controlled chronic HTN, no complications38–39 weeks
Poorly controlled or with superimposed preeclampsiaEarlier delivery; individualized
Severe features (SBP ≥160 or DBP ≥110, organ damage)Expedite delivery after stabilization

Postpartum Considerations

  • BP often rises 3–6 days postpartum — close monitoring required
  • Resume or initiate antihypertensives as needed; most are compatible with breastfeeding (labetalol, nifedipine, methyldopa)
  • ACE inhibitors (e.g., enalapril, captopril) are acceptable postpartum and in breastfeeding
  • Evaluate for secondary causes postpartum if not done previously
  • Long-term: chronic hypertension persists — ongoing cardiovascular risk management
This is a shared conversation. Sign in to Orris to start your own chat.